Seventeen patients with stage 4 CKD (estimated glomerular filtration rate 21.9±7.4 mL/min per 1.73 m2) with controlled hypertension who were aged 63.5±13 years and had not been treated with EPO were included in the study. The gene discussed is EPO; the disease is chronic kidney disease.